ArticleNature2020
Addendum: International evaluation of an AI system for breast cancer screening.
Article in Nature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Artificial Intelligence-Enabled Exosomes in Precision Oncology: A Framework for Clinical Utility and Biomedical Applications.Current issues in molecular biology · 2026Review
- Adding artificial intelligence case malignancy scoring to reduce screen-reading workload in breast screening program: results of the retrospective REAI program.La Radiologia medica · 2026Article
- Artificial Intelligence in Obstetrics and Gynecology Nursing: Clinical, Educational, and Ethical Perspectives.Cureus · 2026Review
- Article
- Artificial Intelligence Advancements in Oncology: A Review of Current Trends and Future Directions.Biomedicines · 2025Review
- Diagnosis and typing of leukemia using a single peripheral blood cell through deep learning.Cancer science · 2025Article
- Metabolic-stress-induced mitochondrial calcium dysregulation: a central hub in diabetic cardiomyopathy pathogenesis and treatment.Frontiers in endocrinology · 2025Review
- Radiologists' Communicative Role in Breast Cancer Patient Management: Beyond Diagnosis.Healthcare (Basel, Switzerland) · 2024Review
- Natural language processing to automate a web-based model of care and modernize skin cancer multidisciplinary team meetings.The British journal of surgery · 2024Article
- [Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extensionDiretrizes para relatórios de ensaios clínicos com intervenções que utilizam inteligência artificial: a extensão CONSORT-AI].Revista panamericana de salud publica = Pan American journal of public health · 2024Article
- Predicting tumor deposits in rectal cancer: a combined deep learning model using T2-MR imaging and clinical features.Insights into imaging · 2023Article
- Integrating equity, diversity and inclusion throughout the lifecycle of AI within healthcare: a scoping review protocol.BMJ open · 2023Article
- Identification and validation of a five-gene prognostic signature based on bioinformatics analyses in breast cancer.Heliyon · 2023Article
- Strategies to eliminate cervical cancer in China.Frontiers in oncology · 2023Review
- Harnessing multimodal data integration to advance precision oncology.Nature reviews. Cancer · 2022Review
- Article
- Cannabidiol loaded extracellular vesicles sensitize triple-negative breast cancer to doxorubicin in both in-vitro and in vivo models.International journal of pharmaceutics · 2021Article
- Article
Corrections and comments
- Erratum for
Authors and funding
31 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Identifiers
33057216What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.